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Aortic valve (AV) disease is highly prevalent and a major source of mortality and morbidity. AV 
disease involves extensive extracellular remodeling of the aortic valve. Studies show that chronic use of 
anti-depressants, and adverse mechanical stimuli are individually correlated to AV degeneration through 
remodeling. There appears to be a synergistic mechanism between cyclic stretch of the AV and the 
disruption of 5-HT reuptake mechanism, a signaling pathway involved in various cellular functions. The 
objective of our study is to use an ex vivo system to understand the role of the combination of stretch and 
5-HT reuptake mechanism in remodeling in AV disease. Fresh porcine AV were exposed to uniaxial 
cyclic stretch using a stretch bioreactor at 10% and 15% stretch for three days and concurrently treated 
with: normal media, 5-HT only, 5-HT with four sub-receptor inhibitors or 5-HT with a 5-HT transporter 
antagonist.  A sircol collagen quantitative assay was used to quantify changes in the collagen content, as 
collagen is one of the hallmarks of valvular disease and remodeling. Additionally, 
immunohistochemistry was used for semi-quantitative analysis using collagen degradative marker and 
synthetic marker for analysis. While the addition of 5-HT significantly up regulated Heat Shock Protein-
47, a common collagen molecular chaperone, 5-HT1D and 5-HT1A receptor inhibitors were most 
effective in down regulating HSP-47. Collagen levels of the 5-HT transporter correlated with the levels 
of matrix metalloprotease-1 degradation marker. Investigation of the sub-receptor and transporter parts 
of the 5-HT pathway illustrate that both the degradative and synthetic pathways are involved in the 
increase of collagen due to 5-HT. The results provide clues for design of novel pharmacological 
treatments to counter 5-HT induced valve degeneration, through blocking specific 5-HT receptors.  




Section 1: Introduction 
Aortic valves (AV) play a crucial role in controlling blood flow regulation from the left ventricle 
to the aorta. During systole, the AV opens to allow blood into the aorta while during diastole it closes to 
prevent the blood from flowing backwards. During blood flow regulation, various mechanical stimuli 
such as fluid shear stress, pressure, bending, and stretch act on aortic valves
1
. Recent studies show that 
altered levels of such forces acting upon the leaflets of the aortic valve may cause serious biological and 
pathological changes such as inflammation, calcification, stenosis, and ultimate failure
2
. While certain 
amounts of mechanical stimuli, such as stretch, are required for regulation of AV pathobiology
3
, 
elevated levels of stretch may alter the proteolytic enzyme expression and activity in cells, leading to 
accelerated valve degeneration and disease progression
4,5,6
. Calcific AV disease is the third most 
common cardiovascular disease in the United States of America
7
. This disease leads to aortic stenosis, 
causing the leaflets to harden, and preventing the AV from opening and closing efficiently. This, in turn, 
prevents proper blood flow regulation between the heart and the rest of the body, leading to ultimate 
heart failure.  
 In previous studies of the mechanobiology of porcine aortic valves under normal hemodynamic 
conditions, the valves have been observed to go through a continuous renewal in order to maintain their 
native phenotypes.
8
 Aortic valve leaflets exposed to hypertensive cyclic pressure reflected an increase in 
collagen and sulfated glycosaminoglycan.
9,10,11
 Additionally, the cyclic stretching of porcine aortic 
valves showed an increase in collagen content through either the increase in collagen synthesis or 
decrease in degradation of collagen.
6
  While all of these studies have demonstrated the effect of different 
mechanical forces on porcine aortic valves, further research is necessary to understand the mechanistic 
pathways behind these biological changes. The effect of numerous drugs and endogenous mediators in 
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addition to external stimuli such as stress, pressure, bending, and cyclic stretch of an aortic valve have 
been of constant interest to researchers. 
 
a.                                    b.  
Figure 1: The image in (a) depicts the nerves in the aortic valve that was stained for the presence of 
acetylcholine, a common neurotransmitter involved in the nervous system and peripheral pathway. The 
black lines represent the acetyl choline in the nerves. The two images in (b) illustrate the serotonin (5-
HT) pathway in the heart
12
. 
  In order to gain a better understanding of possible causes of valve disease and the mechanistic 
pathways behind the changes, molecular remodeling is a very important aspect for understanding 
possible novel therapy to prevent the progression of valvular disease.  Serotonin or 5-hydroxytryptamine 
(5-HT) is an endogenous vasoactive neurotransmitter that is heavily involved in regulation of various 
functions in the nervous system and gastrointestinal tract
13
. In a study conducted by Chester et al in 
2008, the immunohistochemical characterization of choline acetyl transferase (an important enzyme 
involved in the synthesis of acetylcholine which is an important and common neurotransmitter of the 
nervous and peripheral systems) in a cross section of a valvular aortic valve reflected the presence of 
nerves in the aortic valves as can be seen in Figure 1. As a neurotransmitter, serotonin is present in the 
nerves of the AV. A native level of serotonin is present in a healthy human body that is needed for 
regular functioning of the gastrointestinal tract and nervous system. When the level of serotonin drops 
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below these native levels, a person goes into clinical depression. With the lower levels of serotonin, the 
psychological functions of the nervous system are negatively affected.   
As a therapeutic approach to depression, doctors prescribe specific antidepressants (e.g. Zoloft®, 
Prozac®, etc.) that are selective serotonin reuptake inhibitors (SSRIs). These antidepressants prevent the 
reuptake of serotonin by the presynaptic neurons of the aortic valve. The inhibition of 5-HT re-uptake 
results in a higher concentration of serotonin in the body and counters the depressed levels of serotonin 
that result in depression. In a study by Connolly HM et al
10
, the overproduction of 5-HT was observed to 
lead to valvular disease in patients with carcinoid tumors. Similarly, elevated circulating levels of 
serotonin have been reported to result in multiple cardiovascular pathologies such as cardiac valve 
fibrosis, systemic hypertension, and pulmonary hypertension.
8
 Some of these studies have concluded 
that by blocking the reuptake of serotonin into the presynaptic neuron, SSRIs can lead to valvular 
disease
14
. Studies have also reported that intake of fenfluramine-phentermine, appetite suppressants that 
also act as SSRIs, have been observed to lead to valvular disease
10,15
. The hallmarks of valve fibrotic 
lesions include excessive cellular proliferation, and increased extracellular matrix synthesis
16, 17
 resulting 
in abnormal thickening of the valve cusp leading to changes in valve mechanical properties. This 




Recent studies indicated that these pathologies can occur via 5-HT-receptor and 5-HT transporter 
(5-HTT) mediated mechanisms. The presence of distinct subsets of 5-HT-receptors in heart valves 
further reinforces the fact that valvular cells have the potential to respond to 5-HT
16,17
. The 5-HT 2A and 
5-HT2B receptor subtypes are key mechanosensitive 5-HT sub-receptors that modulate the valve 
biosynthetic response to elevated serotonin levels 
18
.   
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The current study focuses on understanding the stretch-sensitivity of 5-HT transporters and sub-
receptors and their involvement in 5-HT reuptake mechanisms that modulate valve remodeling. The 
focus of the study is on individuals suffering from depression, a very common disorder, and who are on 
chronic medication, such as dietary supplements, that disrupt the reuptake mechanism. The central 
hypothesis of this research is that aortic valve cusps respond to elevated levels of 5-HT via the knock-
down of stretch-sensitive 5-HT reabsorption by increasing extracellular matrix synthesis and altering 
mechanical properties. Alterations of the extracellular matrix can stiffen the valve and results in stenosis, 
or lead to malcoaptation and regurgitation, leading to poor heart function. The clinical importance of this 
study lies in testing whether 5-HT has such life-threatening effects so that patients who are taking 
medications, such as Paxil® or Zoloft®, that increase 5-HT levels in the blood, may be prescribed 




Section 2: Methods and Materials: 
 
 
Figure 2: Porcine aortic valves obtained from slaughterhouse. Multiple 5 x 16mm sections were 
obtained and coupled to a stretch bioreactor with the use of springs. 
 
Fresh porcine aortic valves were obtained from a local abattoir (Holifield Farms, Covington, 
Georgia) following on-site dissection of the hearts within 10 minutes of slaughter. The valves were then 
transported to the laboratory in sterile, ice-cold Dulbecco’s Phosphate Buffered Saline (PBS). Upon 
arrival to the laboratory, a rectangular section of tissue with an aspect ratio of 16x5 millimeters was 
isolated from the central region of each valve cusp. Circumferentially-oriented tissue sections were 
extracted to be studied. These samples were then randomly assigned to a treatment group and placed 
into a stretch bioreactor where the tissue was coupled to the moving and static rods using springs as 
shown in Figure 2.  
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The Stretch Bioreactor 
 
 
Figure 3: Ex Vivo tensile stretch bioreactor used in this study. The eight wells on both sides were 
coupled to the linear actuator (motor) through which a waveform specific for 10% or 15% stretch was 
input.  
 
           The main function of the stretch bioreactor that can be viewed in Figure 3 was to mimic the 
hemodynamic stretch forces present in the native environment of an aortic valve. Siprogrammer was 
used to input different stretch levels in the linear actuator that is coupled to the bioreactor. The input 
waveform varied according to the stretch level and the relationship varied, as can be observed in Figure 
4, as a linear function of time. Circumferential cyclic 10% or 15% stretch levels were used as 





Figure 4: The linear relationship of the input waveform as a function of time. 
           Each of the wells were filled with a media called Dulbecco’s Modified Eagle medium (DMEM), 
a base medium used to incubate the tissue that was to be stretched.  This media was comprised of 
various components such as ascorbic acid, antibiotics, HEPES buffer, non-essential amino acids, fetal 
bovine serum albumin and water. The exact amounts of each component can be found in the appendix 
A. The media was buffered to a pH value of 7.4 and filtered prior to addition to the experimental 
samples.  
            Table I. Experimental treatments  
Experimental group 5HT concentration Pharmacological blocker Concentration 
Fresh control - - - 
Stretch control (10% 
and 15%) 
- - - 
5HT 1x10
-5
 M - - 
Inhibit 5-HT1A 1x10
-5































The effect of two different concentrations of Paroxetine, a 5-HT transporter silencing RNA, on 
the aortic valve leaflets that were being stretched was tested by adding the aforesaid concentrations to 
the normal DMEM media. Additionally, the receptor part of the serotonin pathway was studied to 
understand which serotonin sub-receptors were highly involved in the collagen synthesis pathway. The 
control group consisted of fresh valves that were preserved immediately after slaughter. The 
concentrations and pharmaceutical names of the different experimental groups are provided in table I. 
The chemical structure of the agents in table I are provided in Appendix C.  
 
Experimental Duration 
            The entire bioreactor was placed in an incubator with 5% CO2 and experiment was run for 72 
hours. Media in the bioreactor was checked to ensure that p
H
 remained at the physiological value of 7.4, 
as the changes in p
H
 may induce unwanted responses such as apoptosis or contamination. If p
H
 levels 
varied, CO2 levels were checked and adjusted to 5%, but if the media discoloration occurred, the media 
was replaced.  
 
Quantification of Collagen Content                                                                                 
            Total pepsin soluble collagen content was determined using the commercially available Sircol 
Collagen assay kit (Biocolor, UK) colorimetric assay. This kit enables to use a quantitative dye-binding 
method to determine the total quantity of pepsin-soluble collagen in the samples. The amount of 
collagen was then normalized by the dry weight of the sample. The protocol and its details are provided 





Immunohistochemical Analysis of Collagen  
            At the conclusion of an experiment, samples were embedded in an embedding media called 
Optimal Cutting Temperature (OCT) and snap frozen. Tissue sections of 5-7 µm were obtained using a 
cryostat. Immunohistochemistry analysis was done on tissue sections for the expressions of lysyl 
oxidase ( a common collagen cross-linking marker), heat shock protein-47 (an important molecular 
chaperone involved in the maturation of collagen molecules), and prolyl hydroxylase (an enzyme that is 
involved in the production of collagen). Images of the slides were taken using a fluorescent microscope. 
A custom-written MATLAB program was used to quantify the area of immunopositive staining per 
image field normalized by the number cells in that image field. The protocol and its details are provided 
in the appendix B. 
 
Statistical Analyses 
  A minimum sample size of at least 6 for each treatment group was obtained. Error bars indicate 







Section 3: Results 
The results from the study reflected interesting and significant aspects about the serotonin 
pathway. The results are divided based on the part of the mechanistic pathway that was focused on. 
 
Serotonin Transporter Results 
The first marker that was experimented with was collagen type I and it is shown in Figure 5.  
Addition of 5-HT led to increase in collagen type I expression and the addition of 5-HT + 5-HTTI led to 
increase in collagen type I as well. At the physiological stretch level, there is a significant increase in the 
collagen type I content in both the 5-HT and 5-HTT inhibitor groups compared to the normal group. A 
significant difference, however, is not observed between the 5-HT and 5-HTT inhibitor groups. 
To understand whether the increase in collagen type I content was due to decreased degradation 
of collagen or increased synthesis of collagen, the expression of several common markers was 
investigated. Matrix Metalloprotease-1 (MMP-1) is the degradative marker that I examined. As can be 
seen in Figure 6, the increase in collagen type I correlated with a decrease in MMP-1 expression. High 
levels of remodeling corresponded to lower levels of collagen type I present, whereas low levels of 
remodeling reflected higher levels of collagen type I present.  
For the synthetic pathway of collagen, enzymes involved in the synthesis of molecules and cross-
linking of newly synthesized molecules are very important expression that can provide critical 
information about a pathway. Prolyl-4-hydroxylase (P4H) is the common collagen synthesizing enzyme 
that I investigated in this study. No significant alterations were observed for the P4H results as seen in 
Figure 7. Lysyl oxidase (LOX) is the common collagen cross-linking marker that I studied in this 
experiment which also did not reflect statistically significant alterations in the presence of the 
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pharmacological blockers as shown in Figure 8. However, a measurable increase with an increasing 
stretch level was observed.  
 
Figure 5: Quantification of collagen type I expression in the 5-HT transporter pathway 
 
 




Figure 7: Quantification of Prolyl-4-hydroxylase in the 5-HT transporter pathway 
 
Figure 8: Expression of Lysyl Oxidase in the 5-HT transporter pathway 
 
Serotonin Sub-Receptor Results: 
For the serotonin sub-receptors, a quantitative assay was first used to observe any differences in 
the quantitative level of pepsin soluble collagen and to determine the effect of the sub-receptors both in 
the presence of serotonin and individually for two main sub-receptors.  As can be observed in Figure 9, 
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the addition of 5-HT, resulted in a significant increase in the level of pepsin soluble collagen in the 
experimental samples. Increasing the stretch level from 10% to 15% stretch also reflected a significant 
change in the level of pepsin soluble collagen. The presence of two of the most common inhibitors in the 
absence of serotonin reflected how the inhibitors maintained the native collagen level in the tissue. In 
comparison to the normal group, the level of collagen decreased in the presence of both the inhibitors 
tested.  
For the sub-receptor part of the serotonin pathway, the two major biological markers that were 
tested to understand the mechanistic pathway of collagen accumulation were the synthetic markers, heat 
shock protein-47 (HSP-47) and LOX.  As shown in Figure 10, the addition of 5-HT led to an increase in 
the expression of Heat Shock Protein 47 at both 10% and 15% stretch. In the presence of any of the 
experimental sub-receptors, the HSP-47 expression decreased but to different extents. The most 
effective sub-receptor inhibitors were the 5-HT1D and 5-HT1A sub-receptors at 10% and 15% stretch 
respectively. Figure 11 illustrates no significant changes for the expression of LOX, a common collagen 





Figure 9: Sircol Collagen Assay Quantitative Assay results for some sub-receptor inhibitors 
 
 
Figure 10: Expression of Heat Shock Protein-47 expression in the 5-HT sub-receptor pathway 
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Section 4: Discussion 
Collagen Type I is the most abundant collagen in the human system. Due to this reason, the 
experimental samples were analyzed for the expression of collagen type I and as shown in Figure 5, the 
level of collagen type I increased significantly with the addition of serotonin and the serotonin 
transporter inhibitor at both the 10% and 15% stretch levels. A statistically significant difference was, 
however, not observed between the serotonin only and serotonin + transporter inhibitor samples. This 
could imply that the dosage or concentration of serotonin transporter inhibitor was not significant 
enough to cause a considerable change in the collagen type I level.  
 In order to understand whether the increase in the expression of collagen type I with the addition 
of serotonin and transporter inhibitor was due to a synthetic pathway or a degradative pathway, several 
markers were tested to observe which pathways demonstrated clear trends. By analyzing the samples for 
the expression of matrixmetalloprotease-2 (MMP-1), an enzyme involved in the collagen degradation 
and remodeling process, the results correlated very clearly with the collagen type I results. A high level 
of remodeling and thus high expression of MMP-1, corresponded with a lower level of collagen type I. 
Similarly, a lower level of remodeling correlated with a high level of collagen type I expression in the 
serotonin groups. Again while the serotonin and serotonin + transporter inhibitor groups were both 
significantly different compared to the normal group, the groups were not significantly different from 
each other.  
Analyzing the samples further with synthetic markers revealed insignificant differences between 
the normal and serotonin groups. Prolyl-4-hydroxylase, a common enzyme involved in the synthesis of 
collagen, and lysyl oxidase, a common collagen cross-linking reagent, did not reflect statistically 
significant differences between the serotonin and normal control groups. While this could imply that 
these may not be the specific synthetic enzyme or cross-linking reagent involved in the synthesis of 
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collagen, it is also possible that the increase in collagen due to synthesis is minute compared to the 
degradation of collagen. Therefore, the results suggest that in the 5-HT transporter part of the pathway, 
high levels of collagen may result from the decreased degradation of collagen and that the increased 
synthesis of collagen is not a contributing factor.  
 Investigation of the serotonin sub-receptor part of the serotonin pathway, the increase in collagen 
observed could be the result of a different set of proteins and biological operations. Analyzing the 
amount of pepsin soluble collagen present in the normal and two of the common mechanosensitive 
groups, the 5-HT2A and 5-HT2B sub-receptor groups, gave results that were very significant as shown in 
Figure 9. With an increase in stretch level from 10% to 15%, the amount of pepsin soluble collagen 
increased. This is consistent with previous studies which have shown that compared to physiological 
stretch levels (10% stretch), the amount of collagen and remodeling that results at pathological stretch 
levels (15% stretch) is higher
3
. Additionally, with the addition of 5-HT the amount of pepsin soluble 
collagen also increased, suggesting that the presence of a higher concentration of 5-HT can result in a 
higher level of pepsin soluble collagen.  
In the presence of the two commonly tested sub-receptors, the amount of pepsin soluble collagen 
decreased but to different extents. Addition of the 5HT 2A inhibitor in the presence of 5-HT, the level of 
collagen decreased by a greater amount than did the level of collagen with the addition of the 2B 
inhibitor in the presence of 5-HT. The 2A and 2B inhibitors were experimentally tested to ensure that 
the drugs themselves did not have any additional effect that would alter the results of the study. With the 
addition of only the sub-receptors without any additional serotonin, the sub-receptors were observed to 
regulate and maintain the native levels of collagen as can be seen in Figure 9. These results suggest that 
the inhibition of mechanosensitive receptors can inhibit the pathological over expression of collagen. 
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In order to understand how the increase in collagen came about for the sub-receptors, a few 
synthetic markers were tested. In Figure 10, the samples were analyzed for the expression of HSP-47, a 
common collagen molecular chaperone that is involved in the folding and maturation of newly 
synthesized collagen molecules. The presence of 5-HT led to a statistically significant increase in the 
expression of HSP-47 at both stretch levels. With the addition of any of the four different sub-receptors, 
the level of collagen was observed to decrease by different amounts. The sub-receptors that were most 
effective in inhibiting the synthesis of collagen were the 1A and 1D sub-receptors at the 10% and 15% 
stretch levels respectively. The least effective sub-receptor at both stretch levels was observed to be the 
2B, which reflected the greatest expression of HSP-47, which could mean that more molecular 
chaperones were present due to the greater amount of newly synthesized collagen molecules that needed 
to be folded. Cross-linking is evident in newly formed collagen molecules.  However, analyzing the 
samples for the expression of LOX did not demonstrate statistically significant results. This could imply 
that LOX might not be the cross-linking reagent involved in this collagen pathway. Therefore, the 
results imply that these higher levels of pepsin soluble collagen may result in the serotonin sub-receptor 
part of the pathway by synthesizing new collagen molecules. In conclusion, the overall increase in 
collagen due to the inhibition of serotonin transporters results in a lower amount of degradation and a 
higher amount of collagen present. With the inhibition of these serotonin transporters, a higher level of 
serotonin can be taken up into the body by the 1A and 1D sub-receptors which were observed to be 
highly involved in the synthetic pathway of collagen.  
In conclusion, the role of serotonin in the remodeling pathway can be through both degradative 
and synthetic pathways. Therefore, any novel therapy to prevent heart disease in patients that take anti-
depressants or anti-dietary medications needs to target the 1A and 1D sub-receptors to prevent 
remodeling of the aortic valve leaflets that could possibly lead to aortic heart valve disease.  
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Appendix A: Experimental materials and reagents 
 
For Tissue Harvesting: 
Reagent Company 
Dulbecco’s phosphate buffered saline (dPBS) 500 mL Sigma #D5773 
Ethanol/Methanol spray bottle  
1 x 6-well plate Fisher #08-772-1B 
1 x surgical scissors McMaster 
Stainless steel dissection tray (big) Fisher/VWR 
Tweezers (small) McMaster 
Cooler with ice  
 
For stretch experiments:  
 
Components Company 
1x scalpel handle (no. 3) Fisher #08-915-2 
Sterile scalpel blades EMS #72044-10 
2x razor blades (0.009”) VWR #55411-050 
Spacer rods  (5 mm, 11 mm, 6mm) McMaster 
Screws and nuts for spacers McMaster 
Stainless steel dissection tray McMaster 
1x 6-well plate Fisher #08-772-1B 
Stainless steel springs (cut-to-length) McMaster #9663K14McMaster 
Tweezers (1 curved, 1 straight) McMaster 
 
For 1 liter of Dulbecco’s Modified Eagles Medium (DMEM, Sigma#D5648) solution: 
 
Reagent amount 
Dulbecco’s Modified Eagles Medium 13.3grams 
Fetal Bovine Serum 100 milliliters 
Ascorbic Acid 2.5 milliliters 
Sodium Bicarbonate 3.7 grams 
Non-essential amino acid (100x) 10 milliliters 
antibiotics (100x) 10 milliliters 
HEPES buffer 25 milliliters 
deionized water volume required to fill solution to 1 Liter 
 
Stretch bioreactor and motor:  
 
Allen key set McMaster 




Tissue processing for Sircol Collagen Assay 
 
 
For snap-freezing tissue: 
 
Reagents Company 
Cryovials EMS #61800-1 
Cryovial holders EMS #61080-1 
Liquid nitrogen  
 
 
Tissue processing for Immunohistochemistry 
 
For frozen block preparation: 
 
Reagent Company 
plastic molds EMS #70180-70184 
 OCT compound EMS #62550-01 
Tweezers (small) McMaster 
Liquid nitrogen IBB mechanical chase 
 
Immunohistochemistry antibody dilutions: 
 
Antibody Dilution  
Heat shock protein 47 1:100 
Lysyl oxidase 1:50 
Collagen type I 1:300 
Prolyl-4-hydroxlase 1:400 





Appendix B: Experimental Protocols 
Day before Experiment 
1. Autoclave scissors and forceps in small sterilization pouch.  
2. Autoclave tray and absorption pad in large sterilization pouch.  
3. Autoclave all spacers, razor blades, surgical tools, screws, nuts and springs in a small sterilization 
pouch.  
4. Pack and sterilize stretch bioreactor in ethylene oxide (EtO) sterilizer.Alternatively, fill wells of 
stretch bioreactor with ethanol/methanol, cover and place under UV overnight (not preferred).  
5. Place all sterilization pouches under UV overnight.  
6. Autoclave dPBS and put in fridge overnight.  
7. On morning of slaughterhouse trip, fill cooler with ice and place dPBS bottle in it.  
 
At slaughterhouse  
1. Spray work area and tray thoroughly with alcohol.  
2. Fill 6-well plate(s) with ice-cold dPBS.  
3. Cut porcine heart between right and non-coronary leaflet and through the septum to reveal all three 
leaflets.  
4. Excise each leaflet, wash in ice-cold  dPBS and place in 6-well plate, keeping track of the anatomical 
position of each leaflet sample.  
5. Repeat 3-4 for each heart.  






1. Use sterile techniques and a laminar flow hood at all times.  
2. Place DMEM from fridge into incubator/water bath at 37°C.  
3. Using the spaced razor blades, cut out a rectangular section of valve tissue from the base/belly region 
of the leaflet.  
4. Thread springs through each of the short ends of the leaflet section.  
5. Couple linear motor to bioreactor.   
6. Mount leaflets in the bioreactor and fill ~8 mL of DMEM in each well and place the bioreactor in the 
incubator.  
7. Start the linear motor using appropriate code within Si Programmer.  
8. Monitor bioreactor at least twice a day. Media should be changed every 1-3 days, or whenever it has 
turned yellow (due to generation of waste/metabolic byproducts). 
 
Note: During the experimental steps, sterile techniques must be used at all times. Wearing face masks is 
not absolutely necessary for porcine tissue, but must be worn at all times for other tissue types (eg: 
human, ovine etc).  Additionally, an alternative to 6-well plates is to use autoclaved plastic containers 
and excise out the entire aortic valve with the root and a portion of the aorta and place it in ice-cold 








Stopping of experiment  
1. Autoclave surgical tools and dPBS well in advance. Refrigerate dPBS.  
2. On day of experiment, bring dPBS to 37ºC in incubator or water bath. Fill 6-well plate with dPBS.  
3. Return stretch bioreactor to laminar flow hood.  
4. Use Si Programmer to stop linear motor.  
5. Remove tissue from stretch bioreactor. If there are still samples in the bioreactor  
(eg: we are looking at different timepoints), immediately cover bioreactor and return to incubator and 
resume the linear motor.  
6. Using scalpel, remove portion of leaflet that was attached to the spring.   
7. Immerse leaflet in dPBS 3x to wash away DMEM. More washes may be necessary. Tissue should 
appear whitish and lose most of the pink color from the DMEM before proceeding to the next steps of 
the protocol. dPBS should not be colder than room temperature as that might result in thermal shock to 
the tissue samples. 
 
Preparation of frozen blocks for histology/immunohistochemistry 
1. Label plastic molds accordingly.  
2. Arrange tissue samples at the base of plastic mold in appropriate orientation.  
3. Fill mold with OCT compound.  
4. Using microdissection forceps “stand” the tissue in the OCT compound. If en face sections are 
required, tissue should be placed face down in the mold.  
5. Fill vacuum flask with liquid nitrogen.  
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6. Using long hemostat, dip OCT block in liquid nitrogen. Ensure that the block is not submerged (liquid 
nitrogen should NEVER contact the OCT directly). Make sure liquid nitrogen does not fall on the OCT 
compound as it will cause bubbles and cracks to develop in the block. 
7. OCT blocks will start to solidify and turn opaque. Keep blocks in liquid nitrogen until just a small 
circle (approximately 5mm in diameter) of OCT on the top face of the block is left to be solidified. This 
will ensure that the block does not crack.  
8. Place frozen blocks in -80°C freezer. 
 
Snap-freezing of tissue for Sircol Collagen Analysis 
1. Label cryovials accordingly.  
2. Place one tissue sample per cyrovial and snap vials into cyrovial holder.  
3. Place entire cryovials into liquid nitrogen (in the dewar).   
4. Transfer cryovials to -80°C freezer. Alternatively, cryovials can be maintained in liquid nitrogen, but 
care should be taken to ensure that the liquid nitrogen level is always topped up. 
 
Pulverization of Cardiac Tissue  
1. Place mortar and pestle, funnel, cryovials into Styrofoam box filled with ~ 2 L+ of liquid N2.  
a. This is to ensure everything is at the same temp and that nothing will stick to the mortar and pestle 
(i.e. frozen grounded-up valve tissue).  
2. Immerse tissue (you only need ~ 1 g for any biochemical study) into the liq. N2 for at least 1 minute.  
3. Using the tongs, bring the mortar out and leave it half filled with liquid N2.  Pull out the pestle and 
tissue and then in a twisting and pulsating downwards motion, push down on tissue, using one hand to 
hold the mortar down.  
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a. Don’t push too fast or too hard because some liq. N2 and bits of tissue will spill out.  
4. Continue grinding and pulverizing until the heart tissue is a very fine granular powder. This may take 
a few minutes.  
a. At times the grinding takes so long that more liq. N2 will have to be added to the mortar.   
b. Use a small plastic cup and be careful when pouring it in (else tissue might spill out).  
c. Add enough liq. N2 to make a nice tissue slurry as this will be important in later steps. 238  
5. When done grinding heart tissue up, use tongs to get the cryovial and funnel. Set the cryovial onto the 
test tube rack and sit it upright.  Insert the small hole of the funnel into the mouth of the cryovial.  
6. Using your gloves, quickly pour the tissue slurry into the funnel-cryovial.  If there is tissue left in the 
mortar, use the spatula (dip it into liq. N2 first) and then scrape the remaining bits in.  Finally, use the 




Sircol Collagen Assay 
Reagent Company information 
Pepsin Sigma#P7000 
Acetic acid 0.50 M Sigma #242843 
Sircol collagen assay kit Accurate Chem #CLRS1000 
 
Procedure: 
1. The tissue is first digested by using pepsin dissolved in 0.5 M acetic acid (buffer) for 48 
hours at 37 °C. During this period, the tissue needs to be stirred. The ratio of pepsin added to 
dry tissue weight is 1:3.  
2. Reagent blanks (100 μL buffer), collagen standard (double aliquots containing 5, 10, 25, 50 
μg) and test samples (10-100 μL) are then prepared. The contents of all tubes are then 
adjusted to 100 μL with the 0.5 M acetic acid buffer.  
3.  Approximately 1 mL of Sircol Dye reagent is then added to the solutions and mixed using a 
mechanical shaker for 30 minutes.  
4. Tubes are then transferred to a micro centrifuge and spun at > 10,000 xg for 10 minutes.  
5.  Tubes are then inverted to drain the unbound dye.  
6.  Approximately 1 mL of alkali reagent is added and the solution mixed.  
7.  Approximately 200 μL aliquots of samples are taken from the tubes and put into a 96-well 
multi-well plate.  






Slides were first thawed to room temperature, and permeabilized in acetone at -20°C for 
approximately 5 minutes followed by a few 5 minute washes in phosphate buffered saline (PBS, Sigma). 
Sections were then blocked using either 10% animal serum in 10% Bovine Serum Albumin (BSA)/ 1 
molar PBS for 30 minutes. The choice of animal serum to use as the blocking agent depended on the 
species that the secondary antibody was raised in. This step is to ensure that there is no non-specific 
binding of the secondary antibody to the section. Following the blocking step, the slides were then 
incubated in primary antibody in  10% blocker overnight to ensure efficient staining. The sections were 
then saturated in biotinylated secondary antibody (Vector laboratories) in 10% Bovine Serum Albumin 
(BSA)/ 1 molar PBS for 1 hour. Subsequently, Avidin-D Texas red (Vector Laboratories) fluorochrome 
was applied to the sections after the secondary antibody was washed off, for 1 hour. The slides were 
washed in 1 molar PBS for approximately 15 minutes between the different antibodies. The sections 
were then counterstained with 0.25 μgmL-14',6-Diamidino-2-phenylindole (DAPI;  Sigma) for 5 
minutes, coverslipped  and stored at 4 o C. Slides were subsequently imaged under a mercury lamp 
using a FITC/DAPI filter. Images were then analyzed using the ImageJ program by setting the threshold 
for the DAPI stains and biological markers at constant values throughout all of the images analyzed for 






Figure 12. Structure of Paroxetine 
 





Figure 14. Structure of Ketanserin (5-HT-2A inhibitor) 
 
 






Figure 16. Structure of BRL14472 (5-HT-1D inhibitor) 
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